Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-022914
Filing Date
2024-09-05
Accepted
2024-09-05 16:31:10
Documents
1
Period of Report
2024-09-03

Document Format Files

Seq Description Document Type Size
1 form4-09052024_080906.html 4  
1 form4-09052024_080906.xml 4 4067
  Complete submission text file 0001415889-24-022914.txt   5540
Mailing Address C/O EMERGENT BIOSOLUTIONS INC. 300 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address
PAPA JOSEPH C (Reporting) CIK: 0001242215 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38899 | Film No.: 241281806

Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Issuer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)